Evaluation of Door-to-Needle Times Between Alteplase and Tenecteplase for Acute Ischemic Stroke at Two Academic Medical Centers
Tenecteplase and alteplase had comparable DTN times for treatment of AIS and similar safety endpoints. Further studies are warranted to identify opportunities to streamline DTN times with tenecteplase.
Authors
- Andrew Webb (ORCID: https://orcid.org/0000-0003-3425-7181)
- Christopher D. Anderson (ORCID: https://orcid.org/0000-0002-0053-2002)
- Linda Bresette
- Lydia R. Ware (ORCID: https://orcid.org/0000-0001-9880-2017)
- Kaylee Marino (ORCID: https://orcid.org/0000-0003-0003-0261)
- Melanie Goodberlet (ORCID: https://orcid.org/0000-0002-8241-5167)
- Aneesh B. Singhal (ORCID: https://orcid.org/0000-0002-2641-5277)
- Nicholas J. Monkemeyer (ORCID: https://orcid.org/0009-0009-3025-6510)
Institutions
- Brigham and Women's Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1177/10600280241300230
- Citations
- 2
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.77